Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 151Leukemia 138Leukemia, Myeloid, Acute 127Myelodysplastic Syndromes 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Lymphoma 87Lymphoma, Non-Hodgkin 86Multiple Myeloma 84Hodgkin Disease 81Lymphoma, Mantle-Cell 71Lymphoma, Follicular 68Lymphoma, Large B-Cell, Diffuse 60Congenital Abnormalities 59Myeloproliferative Disorders 58Lymphoma, B-Cell, Marginal Zone 58Leukemia, Myeloid, Chronic-Phase 56Leukemia, Myelomonocytic, Chronic 52Leukemia, Myeloid, Accelerated Phase 50Burkitt Lymphoma 50Leukemia, Myelogenous, Chronic, BCR-ABL Positive 46Lymphoma, Large-Cell, Immunoblastic 43Anemia, Refractory, with Excess of Blasts 42Waldenstrom Macroglobulinemia 41Blast Crisis 40Primary Myelofibrosis 38Melanoma 35Recurrence 34Neoplasms, Plasma Cell 34Dendritic Cell Sarcoma, Interdigitating 30Lymphoma, T-Cell, Cutaneous 29

Interventions

human papillomavirus vaccine, L1 type 16, 18 35Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 23Papillomavirus Vaccines 14Data Collection 7Blood Specimen Collection 7Vaccines 6Vaccines, Synthetic 5Educational Status 5Radiotherapy, Intensity-Modulated 4Human Papillomavirus Recombinant Vaccine nonavalent 4Early Intervention, Educational 4Vaginal Smears 3Surveys and Questionnaires 3Polymerase Chain Reaction 3Paclitaxel 3Methods 3Engerix-B 3Colposcopy 3Cisplatin 3halofantrine 2fludarabine phosphate 2fludarabine 2aldesleukin 2Watchful Waiting 2Taxes 2Patient Navigation 2Papanicolaou Test 2Observation 2Light Coagulation 2Imiquimod 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Papillomavirus Infections × fludarabine phosphate × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

NCT01585428 2018-03-07

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
29 enrolled 12 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡